Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Lock-Up Expiration Hell Portfolio -- Ignore unavailable to you. Want to Upgrade?

To: tuck who wrote (724)	10/18/2002 12:44:28 PM
From: Jibacoa	Respond to of 1005

I suppose some patients with lung and other cancers will consider using Vermox off label in view of the relatively low toxicity compared with Taxol and the pretty good results of the drug in vitro and in vivo, albeit those results so far have to be confirmed in a clical trial. I have a small position on INGN and will wait for the stock to close above $3 and $5.30 before adding more.(The 182K that Mahendra Shah Ph.D. bought on July 24 through EJ FNCL ETPRS INC.,were at a price of $0.229 I would like to be able to buy some at that price. <g>)The stock is still selling above book and above its cash/share.<g> RAGL Bernard